Risk factors for severe and critically ill COVID‐19 patients: a review

Y Gao, M Ding, X Dong, J Zhang, A Kursat Azkur… - Allergy, 2021 - Wiley Online Library
The pandemic of coronavirus disease 2019 (COVID‐19), caused by the severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2), has caused an unprecedented global …

Insulin resistance in COVID-19 and diabetes

N Govender, OP Khaliq, J Moodley, T Naicker - Primary Care Diabetes, 2021 - Elsevier
Background The epidemiology of COVID-19 and its association with cardiometabolic
disorders is poorly understood. This is a narrative review that investigates the effects of …

COVID-19 in relation to hyperglycemia and diabetes mellitus

HM Al-Kuraishy, AI Al-Gareeb, M Alblihed… - Frontiers in …, 2021 - frontiersin.org
Coronavirus disease 2019 (COVID-19), triggered by the severe acute respiratory syndrome-
coronavirus 2 (SARS-CoV-2), may lead to extrapulmonary manifestations like diabetes …

Clinical characteristics and short term outcomes after recovery from COVID-19 in patients with and without diabetes in Bangladesh

F Akter, A Mannan, HMH Mehedi, MA Rob… - Diabetes & Metabolic …, 2020 - Elsevier
Background and aims This study investigated the clinical manifestations, outcomes and long-
term complications of COVID-19 inpatients in southern part of Bangladesh while …

Links between COVID-19 and Parkinson's disease/Alzheimer's disease: reciprocal impacts, medical care strategies and underlying mechanisms

P Huang, LY Zhang, YY Tan, SD Chen - Translational Neurodegeneration, 2023 - Springer
The impact of coronavirus disease 2019 (COVID-19) pandemic on patients with
neurodegenerative diseases and the specific neurological manifestations of COVID-19 have …

Periodontitis and coronavirus disease 2019

F Tamimi, S Altigani, M Sanz - Periodontology 2000, 2022 - Wiley Online Library
The coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2
is usually a mild condition; however, in some cases it can result in severe sickness and even …

A narrative review on characterization of acute respiratory distress syndrome in COVID-19-infected lungs using artificial intelligence

JS Suri, S Agarwal, SK Gupta, A Puvvula… - Computers in Biology …, 2021 - Elsevier
Abstract COVID-19 has infected 77.4 million people worldwide and has caused 1.7 million
fatalities as of December 21, 2020. The primary cause of death due to COVID-19 is Acute …

Pre-admission use of sodium glucose transporter-2 inhibitor (SGLT-2i) may significantly improves Covid-19 outcomes in patients with diabetes: A systematic review …

H Permana, TA Yanto, TI Hariyanto - Diabetes Research and Clinical …, 2023 - Elsevier
Aims This study aims to examine the effectiveness of using sodium glucose transporter-2
inhibitor (SGLT-2i) before hospital admission on Covid-19 outcomes in diabetic patients …

Anti-inflammatory adipokines: chemerin, vaspin, omentin concentrations and SARS-CoV-2 outcomes

M Kukla, T Menżyk, M Dembiński, M Winiarski… - Scientific reports, 2021 - nature.com
Abstract Coronavirus disease 2019 (COVID-19) is associated with systemic inflammation. A
wide range of adipokines activities suggests they influence pathogenesis and infection …

The disproportionate impact of COVID-19 among undocumented immigrants and racial minorities in the US

MT Hasan Bhuiyan, I Mahmud Khan… - International journal of …, 2021 - mdpi.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for
coronavirus disease 2019 (COVID-19), has had an unprecedented effect, especially among …